Chi Eziefula

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

Rishi K Gupta, Ewen M. Harrison, Antonia Ho et al. · The Lancet Respiratory Medicine · 2021 · 224 citations · Full text

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Chloë I. Bloom, Thomas M Drake, Annemarie B Docherty et al. · The Lancet Respiratory Medicine · 2021 · 192 citations · Full text

G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests

Gonzalo J. Domingo, Ari Winasti Satyagraha, Anup Anvikar et al. · Malaria Journal · 2013 · 161 citations · Full text

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

Thomas M Drake, Aya Riad, Cameron J Fairfield et al. · The Lancet · 2021 · 161 citations · Full text

Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial

Chi Eziefula, Teun Bousema, Shunmay Yeung et al. · The Lancet Infectious Diseases · 2013 · 113 citations · Full text

Malaria, Uncomplicated Malaria, Parasite Control +3